Obesity and atrial fibrillation: making inroads through fat

Abstract The global prevalence of obesity has reached epidemic proportions, paralleled by a rise in cases of atrial fibrillation (AF). Data from epidemiological cohorts support the role of obesity as an independent risk factor for AF. Increasing evidence indicates that obesity may contribute to the...

Full description

Saved in:
Bibliographic Details
Published inEuropean heart journal. Cardiovascular pharmacotherapy Vol. 7; no. 1; pp. 59 - 67
Main Authors Javed, Saad, Gupta, Dhiraj, Lip, Gregory Y H
Format Journal Article
LanguageEnglish
Published England Oxford University Press 01.01.2021
Subjects
Adipose tissues
Analysis
Atrial fibrillation
Atrial Fibrillation - epidemiology
Cardiac arrhythmia
Epidemiology
Health aspects
Humans
Obesity
Obesity - epidemiology
Risk factors
Strategic planning (Business)
Weight control
Weight loss
Fat
Obesity
Cardiac risk factors
Atrial fibrillation
Online AccessGet full text

Cover

Abstract Abstract The global prevalence of obesity has reached epidemic proportions, paralleled by a rise in cases of atrial fibrillation (AF). Data from epidemiological cohorts support the role of obesity as an independent risk factor for AF. Increasing evidence indicates that obesity may contribute to the AF substrate through a number of pathways including by altering epicardial adipose tissue biology, inflammatory pathways, structural cardiac remodelling, and inducing atrial fibrosis. Due to changes in pharmacokinetics and pharmacodynamics, specific therapeutic considerations are required to guide management of patients with AF including anticoagulation and rhythm control. Also, weight loss in patients with AF has been associated with reduced progression from paroxysmal to persistent AF and indeed regression from persistent to proximal AF. However, the role of dietary intervention in AF control remains to be fully elucidated and hard prospective outcome data to support weight loss are required in AF to determine its role as part of a comprehensive risk factor management strategy for AF in obese patients.
AbstractList The global prevalence of obesity has reached epidemic proportions, paralleled by a rise in cases of atrial fibrillation (AF). Data from epidemiological cohorts support the role of obesity as an independent risk factor for AF. Increasing evidence indicates that obesity may contribute to the AF substrate through a number of pathways including by altering epicardial adipose tissue biology, inflammatory pathways, structural cardiac remodelling, and inducing atrial fibrosis. Due to changes in pharmacokinetics and pharmacodynamics, specific therapeutic considerations are required to guide management of patients with AF including anticoagulation and rhythm control. Also, weight loss in patients with AF has been associated with reduced progression from paroxysmal to persistent AF and indeed regression from persistent to proximal AF. However, the role of dietary intervention in AF control remains to be fully elucidated and hard prospective outcome data to support weight loss are required in AF to determine its role as part of a comprehensive risk factor management strategy for AF in obese patients.The global prevalence of obesity has reached epidemic proportions, paralleled by a rise in cases of atrial fibrillation (AF). Data from epidemiological cohorts support the role of obesity as an independent risk factor for AF. Increasing evidence indicates that obesity may contribute to the AF substrate through a number of pathways including by altering epicardial adipose tissue biology, inflammatory pathways, structural cardiac remodelling, and inducing atrial fibrosis. Due to changes in pharmacokinetics and pharmacodynamics, specific therapeutic considerations are required to guide management of patients with AF including anticoagulation and rhythm control. Also, weight loss in patients with AF has been associated with reduced progression from paroxysmal to persistent AF and indeed regression from persistent to proximal AF. However, the role of dietary intervention in AF control remains to be fully elucidated and hard prospective outcome data to support weight loss are required in AF to determine its role as part of a comprehensive risk factor management strategy for AF in obese patients.
The global prevalence of obesity has reached epidemic proportions, paralleled by a rise in cases of atrial fibrillation (AF). Data from epidemiological cohorts support the role of obesity as an independent risk factor for AF. Increasing evidence indicates that obesity may contribute to the AF substrate through a number of pathways including by altering epicardial adipose tissue biology, inflammatory pathways, structural cardiac remodelling, and inducing atrial fibrosis. Due to changes in pharmacokinetics and pharmacodynamics, specific therapeutic considerations are required to guide management of patients with AF including anticoagulation and rhythm control. Also, weight loss in patients with AF has been associated with reduced progression from paroxysmal to persistent AF and indeed regression from persistent to proximal AF. However, the role of dietary intervention in AF control remains to be fully elucidated and hard prospective outcome data to support weight loss are required in AF to determine its role as part of a comprehensive risk factor management strategy for AF in obese patients.
The global prevalence of obesity has reached epidemic proportions, paralleled by a rise in cases of atrial fibrillation (AF). Data from epidemiological cohorts support the role of obesity as an independent risk factor for AF. Increasing evidence indicates that obesity may contribute to the AF substrate through a number of pathways including by altering epicardial adipose tissue biology, inflammatory pathways, structural cardiac remodelling, and inducing atrial fibrosis. Due to changes in pharmacokinetics and pharmacodynamics, specific therapeutic considerations are required to guide management of patients with AF including anticoagulation and rhythm control. Also, weight loss in patients with AF has been associated with reduced progression from paroxysmal to persistent AF and indeed regression from persistent to proximal AF. However, the role of dietary intervention in AF control remains to be fully elucidated and hard prospective outcome data to support weight loss are required in AF to determine its role as part of a comprehensive risk factor management strategy for AF in obese patients. Keywords Atrial fibrillation * Obesity * Cardiac risk factors * Fat
Abstract The global prevalence of obesity has reached epidemic proportions, paralleled by a rise in cases of atrial fibrillation (AF). Data from epidemiological cohorts support the role of obesity as an independent risk factor for AF. Increasing evidence indicates that obesity may contribute to the AF substrate through a number of pathways including by altering epicardial adipose tissue biology, inflammatory pathways, structural cardiac remodelling, and inducing atrial fibrosis. Due to changes in pharmacokinetics and pharmacodynamics, specific therapeutic considerations are required to guide management of patients with AF including anticoagulation and rhythm control. Also, weight loss in patients with AF has been associated with reduced progression from paroxysmal to persistent AF and indeed regression from persistent to proximal AF. However, the role of dietary intervention in AF control remains to be fully elucidated and hard prospective outcome data to support weight loss are required in AF to determine its role as part of a comprehensive risk factor management strategy for AF in obese patients.
Audience Academic
Author Javed, Saad
Lip, Gregory Y H
Gupta, Dhiraj
Author_xml – sequence: 1
  givenname: Saad
  orcidid: 0000-0002-8039-0373
  surname: Javed
  fullname: Javed, Saad
  organization: Liverpool Centre for Cardiovascular Science, University of Liverpool, Liverpool Heart and Chest Hospital, Liverpool, UK
– sequence: 2
  givenname: Dhiraj
  surname: Gupta
  fullname: Gupta, Dhiraj
  organization: Liverpool Centre for Cardiovascular Science, University of Liverpool, Liverpool Heart and Chest Hospital, Liverpool, UK
– sequence: 3
  givenname: Gregory Y H
  surname: Lip
  fullname: Lip, Gregory Y H
  email: gregory.lip@liverpool.ac.uk
  organization: Liverpool Centre for Cardiovascular Science, University of Liverpool, Liverpool Heart and Chest Hospital, Liverpool, UK
BackLink https://www.ncbi.nlm.nih.gov/pubmed/32096865$$D View this record in MEDLINE/PubMed
BookMark eNqFkc9rHCEUx6WkNGmaa49loJf2sIn6RkfbUwj9BYFc2rO4_th1OzNO1Qnkv6_b3SQ0JAQP-uTz_b7H-75GB2McHUJvCT4lWMKZW2_M9XQ2XWuNCbxARxQztuCiZQd3b-gO0UnOG4wx4YJTAa_QIVAsa8GO0Oerpcuh3DR6tI0uKei-8WGZQt_rEuL4qRn07zCumjCmqG1uyjrFebVuvC5v0Euv--xO9vcx-vX1y8-L74vLq28_Ls4vF4YBLgsuOXRaG0q9oxw4eG87Jy1usRNSE2EFeMnY0oIRjGjAwrqWcyMFZa1ncIw-7HynFP_MLhc1hGxcnXB0cc6KAm8xtKKjFX3_AN3EOY11OkUZASK7DuCeWuneqTD6WJI2W1N1ziXGkhK6bXv6CFWPdUMwNQkf6v9_gnf75vNycFZNKQw63ajbbVeg3QEmxZyT88qE8m_N1Tn0imC1zVXtclX7XO8HuZPdOj8p-LgTxHl6jv0LMLuyiA
CitedBy_id crossref_primary_10_15829_1560_4071_2024_5659
crossref_primary_10_2147_VHRM_S444894
crossref_primary_10_3389_fcvm_2023_1242805
crossref_primary_10_1038_s41366_024_01707_z
crossref_primary_10_1093_ehjcvp_pvac035
crossref_primary_10_3390_biomedicines10112963
crossref_primary_10_1111_jce_16448
crossref_primary_10_1097_HCO_0000000000001004
crossref_primary_10_1186_s12916_022_02505_y
crossref_primary_10_1093_eurjpc_zwac187
crossref_primary_10_23946_2500_0764_2020_6_2_103_115
crossref_primary_10_1111_cob_12424
crossref_primary_10_35366_111550
crossref_primary_10_3390_ijms23158291
crossref_primary_10_1016_j_hrtlng_2025_02_008
crossref_primary_10_1111_pace_14489
crossref_primary_10_1111_jce_15301
crossref_primary_10_1016_j_ijcha_2024_101516
crossref_primary_10_1016_j_jfma_2023_03_013
crossref_primary_10_3390_biomedicines10092268
crossref_primary_10_1186_s12872_024_03731_3
crossref_primary_10_1007_s10557_022_07361_9
crossref_primary_10_1016_j_abb_2025_110325
crossref_primary_10_2147_DMSO_S274047
crossref_primary_10_3390_nu14091878
crossref_primary_10_1016_j_hrthm_2025_03_1942
crossref_primary_10_15829_1560_4071_2021_4343
crossref_primary_10_1016_j_mayocp_2021_12_018
crossref_primary_10_3389_fcvm_2021_732828
crossref_primary_10_3389_fphys_2020_611860
crossref_primary_10_1016_j_jelectrocard_2023_01_001
crossref_primary_10_3390_jcdd9080275
crossref_primary_10_3390_medicina60081190
crossref_primary_10_3390_jcm13113294
crossref_primary_10_1093_eurjpc_zwad333
crossref_primary_10_1093_ehjcvp_pvab087
crossref_primary_10_3389_fcvm_2024_1453127
crossref_primary_10_3390_ijms23169338
crossref_primary_10_7759_cureus_31205
crossref_primary_10_1002_ejhf_2308
crossref_primary_10_1002_clc_23416
crossref_primary_10_1002_ejhf_2728
crossref_primary_10_1253_circrep_CR_23_0073
crossref_primary_10_1007_s11096_023_01583_z
crossref_primary_10_1002_ehf2_14448
crossref_primary_10_1111_jce_16090
crossref_primary_10_3390_physiologia3010004
crossref_primary_10_1007_s11010_022_04562_6
crossref_primary_10_1080_14779072_2022_2067144
Cites_doi 10.1016/j.jacc.2016.09.940
10.1161/CIRCULATIONAHA.105.595140
10.1161/CIRCEP.116.004378
10.1161/01.CIR.86.5.1415
10.1161/CIRCEP.111.964783
10.1161/CIRCULATIONAHA.110.009035
10.1016/j.jacc.2010.11.045
10.1007/s00395-012-0293-1
10.1016/j.jacc.2015.07.084
10.1016/j.amjcard.2018.01.019
10.1111/j.1365-2710.2008.00987.x
10.1002/oby.21718
10.1161/01.CIR.0000099542.57313.C5
10.1093/eurheartj/ehl360
10.1161/CIRCULATIONAHA.105.553743
10.1126/scitranslmed.aal2658
10.1111/jth.13323
10.1136/heartjnl-2018-313490
10.1007/s00392-017-1102-5
10.1016/j.jacc.2010.03.071
10.1016/j.ijcard.2009.10.022
10.1371/journal.pone.0147065
10.1016/j.jacc.2017.09.002
10.1016/j.jacc.2006.08.060
10.1161/CIRCEP.112.971200
10.1093/eurheartj/eht099
10.1161/CIRCULATIONAHA.106.681304
10.1161/STROKEAHA.116.015984
10.1253/circj.CJ-15-0138
10.1016/j.jacc.2015.03.002
10.1164/rccm.200509-1442OC
10.1002/clc.22591
10.1016/j.ijcard.2015.05.129
10.1016/j.jjcc.2015.04.002
10.1093/cvr/cvw001
10.1007/s13679-016-0235-6
10.1016/j.jacc.2015.04.058
10.1016/j.jacc.2009.07.034
10.15420/aer.2018.76.2
10.1093/europace/euw161
10.1161/CIRCEP.109.912055
10.1016/j.ahj.2015.11.016
10.1016/j.jacc.2010.02.029
10.1016/j.amjcard.2008.05.038
10.1007/s11239-012-0811-x
10.1016/j.hrthm.2012.08.043
10.1016/j.amjmed.2005.01.031
10.1111/jce.13786
10.1016/S0140-6736(11)60814-3
10.1161/STROKEAHA.115.011876
10.1016/j.ahj.2015.07.026
10.1001/jama.2013.280521
10.1093/eurheartj/ehn324
10.1093/europace/euy117
10.1093/europace/eus422
10.1016/j.ijcard.2017.03.103
10.1001/jama.292.20.2471
10.1093/eurheartj/ehw124
10.1016/j.jacc.2014.09.028
10.1016/j.mayocp.2016.08.022
10.1016/j.hlc.2007.04.006
10.1093/eurheartj/ehy066
10.1161/01.CIR.0000103131.70301.4F
10.1016/j.jacep.2015.04.004
10.1161/CIRCEP.112.975144
10.2165/00003088-198611030-00002
10.1016/S0140-6736(05)66585-3
10.1016/j.ebiom.2018.08.034
10.1016/j.trsl.2014.04.010
10.1016/j.amjcard.2012.10.013
10.1016/j.ahj.2015.02.008
ContentType Journal Article
Copyright Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) 2020. For permissions, please email: journals.permissions@oup.com. 2020
Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) 2020. For permissions, please email: journals.permissions@oup.com.
COPYRIGHT 2021 Oxford University Press
Copyright_xml – notice: Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) 2020. For permissions, please email: journals.permissions@oup.com. 2020
– notice: Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) 2020. For permissions, please email: journals.permissions@oup.com.
– notice: COPYRIGHT 2021 Oxford University Press
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7X7
7XB
88E
8FI
8FJ
8FK
ABUWG
AFKRA
BENPR
CCPQU
FYUFA
GHDGH
K9.
M0S
M1P
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
7X8
DOI 10.1093/ehjcvp/pvaa013
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central
ProQuest One
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
ProQuest Health & Medical Collection
Medical Database
ProQuest Central Premium
ProQuest One Academic
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest One Academic Middle East (New)
ProQuest One Academic Eastern Edition
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
ProQuest Central
ProQuest Health & Medical Complete
ProQuest Health & Medical Research Collection
Health Research Premium Collection
ProQuest Medical Library
ProQuest One Academic UKI Edition
Health and Medicine Complete (Alumni Edition)
Health & Medical Research Collection
ProQuest Central (New)
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Medical Library (Alumni)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic

CrossRef

ProQuest One Academic Middle East (New)
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: 7X7
  name: Health & Medical Collection
  url: https://search.proquest.com/healthcomplete
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Pharmacy, Therapeutics, & Pharmacology
EISSN 2055-6845
EndPage 67
ExternalDocumentID A690092125
32096865
10_1093_ehjcvp_pvaa013
10.1093/ehjcvp/pvaa013
Genre Journal Article
GroupedDBID 0R~
1TH
3V.
4.4
48X
53G
5WD
7X7
88E
8FI
8FJ
AABZA
AACZT
AAJQQ
AAOGV
AAPQZ
AAPXW
AARHZ
AASNB
AAUAY
AAUQX
AAVAP
ABNHQ
ABPQP
ABPTD
ABQLI
ABQNK
ABUWG
ABWST
ABXVV
ADBBV
ADGZP
ADHKW
ADIPN
ADQBN
ADRTK
ADVEK
AETBJ
AEWNT
AFFZL
AFKRA
AFOFC
AFXEN
AGINJ
AGQXC
AGUTN
AHMBA
AJEEA
ALIPV
ALMA_UNASSIGNED_HOLDINGS
ATGXG
AVWKF
BAYMD
BCRHZ
BENPR
BEYMZ
BHONS
BPHCQ
BTRTY
BVXVI
C45
CCPQU
CDBKE
DAKXR
EBS
EJD
ENERS
FECEO
FLUFQ
FOEOM
FOTVD
FQBLK
FYUFA
GAUVT
GJXCC
H13
HMCUK
IAO
KBUDW
KOP
KSI
KSN
M1P
MHKGH
NOMLY
NOYVH
O9-
OAUYM
OAWHX
OCZFY
ODMLO
OJZSN
OPAEJ
OVD
OWPYF
PAFKI
PEELM
PQQKQ
PROAC
PSQYO
ROX
RUSNO
RXO
TEORI
TJX
UKHRP
YAYTL
YKOAZ
YXANX
AAYXX
ABEJV
ABGNP
ABVGC
ADNBA
ADPDF
AEMQT
AFXAL
AHGBF
AJNCP
ALXQX
AMNDL
CITATION
IHR
ITC
NU-
PHGZM
PHGZT
RPM
TOX
AHMMS
CGR
CUY
CVF
ECM
EIF
NPM
PMFND
7XB
8FK
K9.
PJZUB
PKEHL
PPXIY
PQEST
PQUKI
7X8
ID FETCH-LOGICAL-c530t-69637aac22fe26363ffd7e9d040e89a18d83f955bd3c851a308de466c98254f53
IEDL.DBID 7X7
ISSN 2055-6837
2055-6845
IngestDate Fri Jul 11 03:03:13 EDT 2025
Wed Aug 20 03:12:23 EDT 2025
Tue Jun 17 21:36:53 EDT 2025
Tue Jun 10 20:48:01 EDT 2025
Thu Apr 03 07:10:12 EDT 2025
Tue Jul 01 01:13:55 EDT 2025
Thu Apr 24 23:07:34 EDT 2025
Wed Aug 28 03:18:37 EDT 2024
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Fat
Obesity
Cardiac risk factors
Atrial fibrillation
Language English
License This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model)
https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model
Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) 2020. For permissions, please email: journals.permissions@oup.com.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c530t-69637aac22fe26363ffd7e9d040e89a18d83f955bd3c851a308de466c98254f53
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0002-8039-0373
OpenAccessLink https://academic.oup.com/ehjcvp/article-pdf/7/1/59/35904822/pvaa013.pdf
PMID 32096865
PQID 2513197733
PQPubID 2046366
PageCount 9
ParticipantIDs proquest_miscellaneous_2364034872
proquest_journals_2513197733
gale_infotracmisc_A690092125
gale_infotracacademiconefile_A690092125
pubmed_primary_32096865
crossref_citationtrail_10_1093_ehjcvp_pvaa013
crossref_primary_10_1093_ehjcvp_pvaa013
oup_primary_10_1093_ehjcvp_pvaa013
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2021-01-01
PublicationDateYYYYMMDD 2021-01-01
PublicationDate_xml – month: 01
  year: 2021
  text: 2021-01-01
  day: 01
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
– name: Oxford
PublicationTitle European heart journal. Cardiovascular pharmacotherapy
PublicationTitleAlternate Eur Heart J Cardiovasc Pharmacother
PublicationYear 2021
Publisher Oxford University Press
Publisher_xml – name: Oxford University Press
References Miyasaka (2021011615243832200_pvaa013-B7) 2006; 114
Berkovitch (2021011615243832200_pvaa013-B17) 2016; 173
Hatem (2021011615243832200_pvaa013-B42) 2016; 109
Tedrow (2021011615243832200_pvaa013-B6) 2010; 55
Goudis (2021011615243832200_pvaa013-B47) 2015; 66
Kim (2021011615243832200_pvaa013-B45) 2011; 4
Long (2021011615243832200_pvaa013-B18) 2011; 148
Verheule (2021011615243832200_pvaa013-B44) 2013; 6
Iacobellis (2021011615243832200_pvaa013-B71) 2017; 25
Wong (2021011615243832200_pvaa013-B30) 2016; 9
Fukuchi (2021011615243832200_pvaa013-B61) 2009; 34
Senoo (2021011615243832200_pvaa013-B55) 2016; 47
Stritzke (2021011615243832200_pvaa013-B37) 2009; 54
Mehra (2021011615243832200_pvaa013-B23) 2006; 173
Karasoy (2021011615243832200_pvaa013-B14) 2013; 15
Aviles (2021011615243832200_pvaa013-B38) 2003; 108
Echahidi (2021011615243832200_pvaa013-B8) 2007; 116
Thanassoulis (2021011615243832200_pvaa013-B28) 2010; 3
Morin (2021011615243832200_pvaa013-B2) 2016; 91
Venteclef (2021011615243832200_pvaa013-B32) 2015; 36
Voskoboinik (2021011615243832200_pvaa013-B58) 2019; 30
Abed (2021011615243832200_pvaa013-B65) 2013; 310
Wong (2021011615243832200_pvaa013-B24) 2017; 38
Kwon (2021011615243832200_pvaa013-B48) 2016; 11
Abed (2021011615243832200_pvaa013-B68) 2015; 169
Zacharias (2021011615243832200_pvaa013-B4) 2005; 112
Al-Rawahi (2021011615243832200_pvaa013-B25) 2015; 195
Harada (2021011615243832200_pvaa013-B39) 2015; 79
Wallace (2021011615243832200_pvaa013-B51) 2013; 36
Mazurek (2021011615243832200_pvaa013-B40) 2003; 108
Lee (2021011615243832200_pvaa013-B16) 2017; 240
De Caterina (2021011615243832200_pvaa013-B56) 2017; 106
Lavie (2021011615243832200_pvaa013-B20) 2017; 70
Shoemaker (2021011615243832200_pvaa013-B60) 2013; 111
Wang (2021011615243832200_pvaa013-B1) 2011; 378
Martin (2021011615243832200_pvaa013-B54) 2016; 14
Pathak (2021011615243832200_pvaa013-B66) 2015; 65
Frost (2021011615243832200_pvaa013-B11) 2005; 118
Goette (2021011615243832200_pvaa013-B36) 2016; 18
Abed (2021011615243832200_pvaa013-B35) 2013; 10
Alpert (2021011615243832200_pvaa013-B19) 2016; 5
Wong (2021011615243832200_pvaa013-B31) 2011; 57
Pathak (2021011615243832200_pvaa013-B67) 2014; 64
Rocca (2021011615243832200_pvaa013-B53) 2018; 39
Lin (2021011615243832200_pvaa013-B34) 2012; 107
Kistler (2021011615243832200_pvaa013-B46) 2006; 27
Proietti (2021011615243832200_pvaa013-B50) 2017; 48
Ayer (2021011615243832200_pvaa013-B22) 2008; 17
Antonopoulos (2021011615243832200_pvaa013-B72) 2017; 9
Nagashima (2021011615243832200_pvaa013-B43) 2012; 5
Tsang (2021011615243832200_pvaa013-B12) 2008; 29
Middeldorp (2021011615243832200_pvaa013-B69) 2018; 20
Fioravanti (2021011615243832200_pvaa013-B70) 2015; 66
Vyas (2021011615243832200_pvaa013-B27) 2019; 8
Abernethy (2021011615243832200_pvaa013-B62) 1986; 11
Gami (2021011615243832200_pvaa013-B5) 2007; 49
Al Chekakie (2021011615243832200_pvaa013-B29) 2010; 56
Deng (2021011615243832200_pvaa013-B10) 2018; 35
Chen (2021011615243832200_pvaa013-B41) 2008; 102
Wang (2021011615243832200_pvaa013-B9) 2004; 292
Buckley (2021011615243832200_pvaa013-B52) 2017; 40
Levy (2021011615243832200_pvaa013-B57) 1992; 86
Glover (2021011615243832200_pvaa013-B59) 2019; 105
Wong (2021011615243832200_pvaa013-B3) 2015; 1
Yudkin (2021011615243832200_pvaa013-B26) 2005; 365
Huxley (2021011615243832200_pvaa013-B15) 2011; 123
Alpert (2021011615243832200_pvaa013-B21) 2014; 164
Mahajan (2021011615243832200_pvaa013-B33) 2015; 66
Jamaly (2021011615243832200_pvaa013-B63) 2016; 68
Alonso (2021011615243832200_pvaa013-B64) 2015; 170
Sandhu (2021011615243832200_pvaa013-B49) 2016; 37
Foy (2021011615243832200_pvaa013-B13) 2018; 121
References_xml – volume: 68
  start-page: 2497
  year: 2016
  ident: 2021011615243832200_pvaa013-B63
  article-title: Bariatric surgery and the risk of new-onset atrial fibrillation in Swedish Obese Subjects
  publication-title: J Am Coll Cardiol
  doi: 10.1016/j.jacc.2016.09.940
– volume: 114
  start-page: 119
  year: 2006
  ident: 2021011615243832200_pvaa013-B7
  article-title: Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence
  publication-title: Circulation
  doi: 10.1161/CIRCULATIONAHA.105.595140
– volume: 9
  year: 2016
  ident: 2021011615243832200_pvaa013-B30
  article-title: Associations of epicardial, abdominal, and overall adiposity with atrial fibrillation
  publication-title: Circ Arrhythm Electrophysiol
  doi: 10.1161/CIRCEP.116.004378
– volume: 86
  start-page: 1415
  year: 1992
  ident: 2021011615243832200_pvaa013-B57
  article-title: A randomized comparison of external and internal cardioversion of chronic atrial fibrillation
  publication-title: Circulation
  doi: 10.1161/01.CIR.86.5.1415
– volume: 4
  start-page: 761
  year: 2011
  ident: 2021011615243832200_pvaa013-B45
  article-title: Atrial remodeling and the substrate for atrial fibrillation in rat hearts with elevated afterload
  publication-title: Circ Arrhythm Electrophysiol
  doi: 10.1161/CIRCEP.111.964783
– volume: 123
  start-page: 1501
  year: 2011
  ident: 2021011615243832200_pvaa013-B15
  article-title: Absolute and attributable risks of atrial fibrillation in relation to optimal and borderline risk factors: the Atherosclerosis Risk in Communities (ARIC) study
  publication-title: Circulation
  doi: 10.1161/CIRCULATIONAHA.110.009035
– volume: 57
  start-page: 1745
  year: 2011
  ident: 2021011615243832200_pvaa013-B31
  article-title: Pericardial fat is associated with atrial fibrillation severity and ablation outcome
  publication-title: J Am Coll Cardiol
  doi: 10.1016/j.jacc.2010.11.045
– volume: 107
  start-page: 293
  year: 2012
  ident: 2021011615243832200_pvaa013-B34
  article-title: Adipocytes modulate the electrophysiology of atrial myocytes: implications in obesity-induced atrial fibrillation
  publication-title: Basic Res Cardiol
  doi: 10.1007/s00395-012-0293-1
– volume: 66
  start-page: 2264
  year: 2015
  ident: 2021011615243832200_pvaa013-B70
  article-title: BMI reduction decreases AF recurrence rate in a Mediterranean cohort
  publication-title: J Am Coll Cardiol
  doi: 10.1016/j.jacc.2015.07.084
– volume: 121
  start-page: 1072
  year: 2018
  ident: 2021011615243832200_pvaa013-B13
  article-title: Relation of obesity to new-onset atrial fibrillation and atrial flutter in adults
  publication-title: Am J Cardiol
  doi: 10.1016/j.amjcard.2018.01.019
– volume: 34
  start-page: 329
  year: 2009
  ident: 2021011615243832200_pvaa013-B61
  article-title: Effect of obesity on serum amiodarone concentration in Japanese patients: population pharmacokinetic investigation by multiple trough screen analysis
  publication-title: J Clin Pharm Ther
  doi: 10.1111/j.1365-2710.2008.00987.x
– volume: 25
  start-page: 311
  year: 2017
  ident: 2021011615243832200_pvaa013-B71
  article-title: Liraglutide causes large and rapid epicardial fat reduction
  publication-title: Obesity (Silver Spring)
  doi: 10.1002/oby.21718
– volume: 108
  start-page: 2460
  year: 2003
  ident: 2021011615243832200_pvaa013-B40
  article-title: Human epicardial adipose tissue is a source of inflammatory mediators
  publication-title: Circulation
  doi: 10.1161/01.CIR.0000099542.57313.C5
– volume: 27
  start-page: 3045
  year: 2006
  ident: 2021011615243832200_pvaa013-B46
  article-title: Atrial electrical and structural abnormalities in an ovine model of chronic blood pressure elevation after prenatal corticosteroid exposure: implications for development of atrial fibrillation
  publication-title: Eur Heart J
  doi: 10.1093/eurheartj/ehl360
– volume: 112
  start-page: 3247
  year: 2005
  ident: 2021011615243832200_pvaa013-B4
  article-title: Obesity and risk of new-onset atrial fibrillation after cardiac surgery
  publication-title: Circulation
  doi: 10.1161/CIRCULATIONAHA.105.553743
– volume: 9
  year: 2017
  ident: 2021011615243832200_pvaa013-B72
  article-title: Detecting human coronary inflammation by imaging perivascular fat
  publication-title: Sci Transl Med
  doi: 10.1126/scitranslmed.aal2658
– volume: 14
  start-page: 1308
  year: 2016
  ident: 2021011615243832200_pvaa013-B54
  article-title: Use of the direct oral anticoagulants in obese patients: guidance from the SSC of the ISTH
  publication-title: J Thromb Haemost
  doi: 10.1111/jth.13323
– volume: 105
  start-page: 244
  year: 2019
  ident: 2021011615243832200_pvaa013-B59
  article-title: Impact of body mass index on the outcome of catheter ablation of atrial fibrillation
  publication-title: Heart
  doi: 10.1136/heartjnl-2018-313490
– volume: 106
  start-page: 565
  year: 2017
  ident: 2021011615243832200_pvaa013-B56
  article-title: The non-vitamin K antagonist oral anticoagulants (NOACs) and extremes of body weight-a systematic literature review
  publication-title: Clin Res Cardiol
  doi: 10.1007/s00392-017-1102-5
– volume: 56
  start-page: 784
  year: 2010
  ident: 2021011615243832200_pvaa013-B29
  article-title: Pericardial fat is independently associated with human atrial fibrillation
  publication-title: J Am Coll Cardiol
  doi: 10.1016/j.jacc.2010.03.071
– volume: 148
  start-page: 48
  year: 2011
  ident: 2021011615243832200_pvaa013-B18
  article-title: Atrial fibrillation and obesity among older Chinese: The Guangzhou Biobank Cohort Study
  publication-title: Int J Cardiol
  doi: 10.1016/j.ijcard.2009.10.022
– volume: 11
  start-page: e0147065
  year: 2016
  ident: 2021011615243832200_pvaa013-B48
  article-title: Association of smoking, alcohol, and obesity with cardiovascular death and ischemic stroke in atrial fibrillation: the Atherosclerosis Risk in Communities (ARIC) study and Cardiovascular Health Study (CHS)
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0147065
– volume: 70
  start-page: 2022
  year: 2017
  ident: 2021011615243832200_pvaa013-B20
  article-title: Obesity and atrial fibrillation prevalence, pathogenesis, and prognosis: effects of weight loss and exercise
  publication-title: J Am Coll Cardiol
  doi: 10.1016/j.jacc.2017.09.002
– volume: 49
  start-page: 565
  year: 2007
  ident: 2021011615243832200_pvaa013-B5
  article-title: Obstructive sleep apnea, obesity, and the risk of incident atrial fibrillation
  publication-title: J Am Coll Cardiol
  doi: 10.1016/j.jacc.2006.08.060
– volume: 5
  start-page: 676
  year: 2012
  ident: 2021011615243832200_pvaa013-B43
  article-title: Does location of epicardial adipose tissue correspond to endocardial high dominant frequency or complex fractionated atrial electrogram sites during atrial fibrillation?
  publication-title: Circ Arrhythm Electrophysiol
  doi: 10.1161/CIRCEP.112.971200
– volume: 36
  start-page: 795
  year: 2015
  ident: 2021011615243832200_pvaa013-B32
  article-title: Human epicardial adipose tissue induces fibrosis of the atrial myocardium through the secretion of adipo-fibrokines
  publication-title: Eur Heart J
  doi: 10.1093/eurheartj/eht099
– volume: 116
  start-page: I213
  year: 2007
  ident: 2021011615243832200_pvaa013-B8
  article-title: Obesity and metabolic syndrome are independent risk factors for atrial fibrillation after coronary artery bypass graft surgery
  publication-title: Circulation
  doi: 10.1161/CIRCULATIONAHA.106.681304
– volume: 48
  start-page: 857
  year: 2017
  ident: 2021011615243832200_pvaa013-B50
  article-title: Is there an obesity paradox for outcomes in atrial fibrillation? A systematic review and meta-analysis of non-vitamin K antagonist oral anticoagulant trials
  publication-title: Stroke
  doi: 10.1161/STROKEAHA.116.015984
– volume: 79
  start-page: 495
  year: 2015
  ident: 2021011615243832200_pvaa013-B39
  article-title: Role of inflammation in atrial fibrillation pathophysiology and management
  publication-title: Circ J
  doi: 10.1253/circj.CJ-15-0138
– volume: 65
  start-page: 2159
  year: 2015
  ident: 2021011615243832200_pvaa013-B66
  article-title: Long-term effect of goal-directed weight management in an atrial fibrillation cohort: a long-term follow-up study (LEGACY)
  publication-title: J Am Coll Cardiol
  doi: 10.1016/j.jacc.2015.03.002
– volume: 173
  start-page: 910
  year: 2006
  ident: 2021011615243832200_pvaa013-B23
  article-title: Association of nocturnal arrhythmias with sleep-disordered breathing: the Sleep Heart Health Study
  publication-title: Am J Respir Crit Care Med
  doi: 10.1164/rccm.200509-1442OC
– volume: 40
  start-page: 46
  year: 2017
  ident: 2021011615243832200_pvaa013-B52
  article-title: Direct oral anticoagulants in patients with atrial fibrillation and renal impairment, extremes in weight, or advanced age
  publication-title: Clin Cardiol
  doi: 10.1002/clc.22591
– volume: 195
  start-page: 98
  year: 2015
  ident: 2021011615243832200_pvaa013-B25
  article-title: Pericardial fat and atrial fibrillation: epidemiology, mechanisms and interventions
  publication-title: Int J Cardiol
  doi: 10.1016/j.ijcard.2015.05.129
– volume: 66
  start-page: 361
  year: 2015
  ident: 2021011615243832200_pvaa013-B47
  article-title: Obesity and atrial fibrillation: a comprehensive review of the pathophysiological mechanisms and links
  publication-title: J Cardiol
  doi: 10.1016/j.jjcc.2015.04.002
– volume: 109
  start-page: 502
  year: 2016
  ident: 2021011615243832200_pvaa013-B42
  article-title: Cardiac adipose tissue and atrial fibrillation: the perils of adiposity
  publication-title: Cardiovasc Res
  doi: 10.1093/cvr/cvw001
– volume: 5
  start-page: 424
  year: 2016
  ident: 2021011615243832200_pvaa013-B19
  article-title: Effects of obesity on cardiovascular hemodynamics, cardiac morphology, and ventricular function
  publication-title: Curr Obes Rep
  doi: 10.1007/s13679-016-0235-6
– volume: 66
  start-page: 1
  year: 2015
  ident: 2021011615243832200_pvaa013-B33
  article-title: Electrophysiological, electroanatomical, and structural remodeling of the atria as consequences of sustained obesity
  publication-title: J Am Coll Cardiol
  doi: 10.1016/j.jacc.2015.04.058
– volume: 54
  start-page: 1982
  year: 2009
  ident: 2021011615243832200_pvaa013-B37
  article-title: The aging process of the heart: obesity is the main risk factor for left atrial enlargement during aging the MONICA/KORA (monitoring of trends and determinations in cardiovascular disease/cooperative research in the region of Augsburg) study
  publication-title: J Am Coll Cardiol
  doi: 10.1016/j.jacc.2009.07.034
– volume: 8
  start-page: 28
  year: 2019
  ident: 2021011615243832200_pvaa013-B27
  article-title: Obesity and atrial fibrillation: epidemiology, pathophysiology and novel therapeutic opportunities
  publication-title: Arrhythm Electrophysiol Rev
  doi: 10.15420/aer.2018.76.2
– volume: 18
  start-page: 1455
  year: 2016
  ident: 2021011615243832200_pvaa013-B36
  article-title: EHRA/HRS/APHRS/SOLAECE expert consensus on atrial cardiomyopathies: definition, characterization, and clinical implication
  publication-title: Europace
  doi: 10.1093/europace/euw161
– volume: 3
  start-page: 345
  year: 2010
  ident: 2021011615243832200_pvaa013-B28
  article-title: Pericardial fat is associated with prevalent atrial fibrillation: the Framingham Heart Study
  publication-title: Circ Arrhythm Electrophysiol
  doi: 10.1161/CIRCEP.109.912055
– volume: 173
  start-page: 41
  year: 2016
  ident: 2021011615243832200_pvaa013-B17
  article-title: Body mass index and the risk of new-onset atrial fibrillation in middle-aged adults
  publication-title: Am Heart J
  doi: 10.1016/j.ahj.2015.11.016
– volume: 55
  start-page: 2319
  year: 2010
  ident: 2021011615243832200_pvaa013-B6
  article-title: The long- and short-term impact of elevated body mass index on the risk of new atrial fibrillation the WHS (Women’s Health Study)
  publication-title: J Am Coll Cardiol
  doi: 10.1016/j.jacc.2010.02.029
– volume: 102
  start-page: 861
  year: 2008
  ident: 2021011615243832200_pvaa013-B41
  article-title: Increased inflammatory cell infiltration in the atrial myocardium of patients with atrial fibrillation
  publication-title: Am J Cardiol
  doi: 10.1016/j.amjcard.2008.05.038
– volume: 36
  start-page: 96
  year: 2013
  ident: 2021011615243832200_pvaa013-B51
  article-title: Comparison of initial warfarin response in obese patients versus non-obese patients
  publication-title: J Thromb Thrombolysis
  doi: 10.1007/s11239-012-0811-x
– volume: 10
  start-page: 90
  year: 2013
  ident: 2021011615243832200_pvaa013-B35
  article-title: Obesity results in progressive atrial structural and electrical remodeling: implications for atrial fibrillation
  publication-title: Heart Rhythm
  doi: 10.1016/j.hrthm.2012.08.043
– volume: 118
  start-page: 489
  year: 2005
  ident: 2021011615243832200_pvaa013-B11
  article-title: Overweight and obesity as risk factors for atrial fibrillation or flutter: the Danish Diet, Cancer, and Health Study
  publication-title: Am J Med
  doi: 10.1016/j.amjmed.2005.01.031
– volume: 30
  start-page: 155
  year: 2019
  ident: 2021011615243832200_pvaa013-B58
  article-title: Cardioversion of atrial fibrillation in obese patients: results from the Cardioversion-BMI randomized controlled trial
  publication-title: J Cardiovasc Electrophysiol
  doi: 10.1111/jce.13786
– volume: 378
  start-page: 815
  year: 2011
  ident: 2021011615243832200_pvaa013-B1
  article-title: Health and economic burden of the projected obesity trends in the USA and the UK
  publication-title: Lancet
  doi: 10.1016/S0140-6736(11)60814-3
– volume: 47
  start-page: 523
  year: 2016
  ident: 2021011615243832200_pvaa013-B55
  article-title: Body mass index and adverse outcomes in elderly patients with atrial fibrillation: the AMADEUS trial
  publication-title: Stroke
  doi: 10.1161/STROKEAHA.115.011876
– volume: 170
  start-page: 770
  year: 2015
  ident: 2021011615243832200_pvaa013-B64
  article-title: Effect of an intensive lifestyle intervention on atrial fibrillation risk in individuals with type 2 diabetes: the Look AHEAD randomized trial
  publication-title: Am Heart J
  doi: 10.1016/j.ahj.2015.07.026
– volume: 310
  start-page: 2050
  year: 2013
  ident: 2021011615243832200_pvaa013-B65
  article-title: Effect of weight reduction and cardiometabolic risk factor management on symptom burden and severity in patients with atrial fibrillation: a randomized clinical trial
  publication-title: JAMA
  doi: 10.1001/jama.2013.280521
– volume: 29
  start-page: 2227
  year: 2008
  ident: 2021011615243832200_pvaa013-B12
  article-title: Obesity as a risk factor for the progression of paroxysmal to permanent atrial fibrillation: a longitudinal cohort study of 21 years
  publication-title: Eur Heart J
  doi: 10.1093/eurheartj/ehn324
– volume: 20
  start-page: 1929
  year: 2018
  ident: 2021011615243832200_pvaa013-B69
  article-title: PREVEntion and regReSsive Effect of weight-loss and risk factor modification on Atrial Fibrillation: the REVERSE-AF study
  publication-title: Europace
  doi: 10.1093/europace/euy117
– volume: 15
  start-page: 781
  year: 2013
  ident: 2021011615243832200_pvaa013-B14
  article-title: Obesity is a risk factor for atrial fibrillation among fertile young women: a nationwide cohort study
  publication-title: Europace
  doi: 10.1093/europace/eus422
– volume: 240
  start-page: 221
  year: 2017
  ident: 2021011615243832200_pvaa013-B16
  article-title: Atrial fibrillation risk in metabolically healthy obesity: A nationwide population-based study
  publication-title: Int J Cardiol
  doi: 10.1016/j.ijcard.2017.03.103
– volume: 292
  start-page: 2471
  year: 2004
  ident: 2021011615243832200_pvaa013-B9
  article-title: Obesity and the risk of new-onset atrial fibrillation
  publication-title: JAMA
  doi: 10.1001/jama.292.20.2471
– volume: 37
  start-page: 2869
  year: 2016
  ident: 2021011615243832200_pvaa013-B49
  article-title: The ‘obesity paradox’ in atrial fibrillation: observations from the ARISTOTLE (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation) trial
  publication-title: Eur Heart J
  doi: 10.1093/eurheartj/ehw124
– volume: 64
  start-page: 2222
  year: 2014
  ident: 2021011615243832200_pvaa013-B67
  article-title: Aggressive risk factor reduction study for atrial fibrillation and implications for the outcome of ablation: the ARREST-AF cohort study
  publication-title: J Am Coll Cardiol
  doi: 10.1016/j.jacc.2014.09.028
– volume: 91
  start-page: 1778
  year: 2016
  ident: 2021011615243832200_pvaa013-B2
  article-title: The state of the art: atrial fibrillation epidemiology, prevention, and treatment
  publication-title: Mayo Clin Proc
  doi: 10.1016/j.mayocp.2016.08.022
– volume: 17
  start-page: 19
  year: 2008
  ident: 2021011615243832200_pvaa013-B22
  article-title: Body mass index is an independent determinant of left atrial size
  publication-title: Heart Lung Circ
  doi: 10.1016/j.hlc.2007.04.006
– volume: 39
  start-page: 1672
  year: 2018
  ident: 2021011615243832200_pvaa013-B53
  article-title: Antithrombotic therapy and body mass: an expert position paper of the ESC Working Group on Thrombosis
  publication-title: Eur Heart J
  doi: 10.1093/eurheartj/ehy066
– volume: 108
  start-page: 3006
  year: 2003
  ident: 2021011615243832200_pvaa013-B38
  article-title: Inflammation as a risk factor for atrial fibrillation
  publication-title: Circulation
  doi: 10.1161/01.CIR.0000103131.70301.4F
– volume: 1
  start-page: 139
  year: 2015
  ident: 2021011615243832200_pvaa013-B3
  article-title: Obesity and the risk of incident, post-operative, and post-ablation atrial fibrillation: a meta-analysis of 626,603 individuals in 51 studies
  publication-title: JACC Clin Electrophysiol
  doi: 10.1016/j.jacep.2015.04.004
– volume: 6
  start-page: 202
  year: 2013
  ident: 2021011615243832200_pvaa013-B44
  article-title: Loss of continuity in the thin epicardial layer because of endomysial fibrosis increases the complexity of atrial fibrillatory conduction
  publication-title: Circ Arrhythm Electrophysiol
  doi: 10.1161/CIRCEP.112.975144
– volume: 11
  start-page: 199
  year: 1986
  ident: 2021011615243832200_pvaa013-B62
  article-title: Drug disposition in obese humans. An update
  publication-title: Clin Pharmacokinet
  doi: 10.2165/00003088-198611030-00002
– volume: 365
  start-page: 1817
  year: 2005
  ident: 2021011615243832200_pvaa013-B26
  article-title: “Vasocrine” signalling from perivascular fat: a mechanism linking insulin resistance to vascular disease
  publication-title: Lancet
  doi: 10.1016/S0140-6736(05)66585-3
– volume: 38
  start-page: 1294
  year: 2017
  ident: 2021011615243832200_pvaa013-B24
  article-title: Epicardial fat and atrial fibrillation: current evidence, potential mechanisms, clinical implications, and future directions
  publication-title: Eur Heart J
– volume: 35
  start-page: 40
  year: 2018
  ident: 2021011615243832200_pvaa013-B10
  article-title: A U-shaped relationship of body mass index on atrial fibrillation recurrence post ablation: a report from the Guangzhou atrial fibrillation ablation registry
  publication-title: EBioMedicine
  doi: 10.1016/j.ebiom.2018.08.034
– volume: 164
  start-page: 345
  year: 2014
  ident: 2021011615243832200_pvaa013-B21
  article-title: Obesity and heart failure: epidemiology, pathophysiology, clinical manifestations, and management
  publication-title: Transl Res
  doi: 10.1016/j.trsl.2014.04.010
– volume: 111
  start-page: 368
  year: 2013
  ident: 2021011615243832200_pvaa013-B60
  article-title: Relation of morbid obesity and female gender to risk of procedural complications in patients undergoing atrial fibrillation ablation
  publication-title: Am J Cardiol
  doi: 10.1016/j.amjcard.2012.10.013
– volume: 169
  start-page: 655
  year: 2015
  ident: 2021011615243832200_pvaa013-B68
  article-title: Impact of weight reduction on pericardial adipose tissue and cardiac structure in patients with atrial fibrillation
  publication-title: Am Heart J
  doi: 10.1016/j.ahj.2015.02.008
SSID ssj0001686283
Score 2.3441455
SecondaryResourceType review_article
Snippet Abstract The global prevalence of obesity has reached epidemic proportions, paralleled by a rise in cases of atrial fibrillation (AF). Data from...
The global prevalence of obesity has reached epidemic proportions, paralleled by a rise in cases of atrial fibrillation (AF). Data from epidemiological cohorts...
SourceID proquest
gale
pubmed
crossref
oup
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 59
SubjectTerms Adipose tissues
Analysis
Atrial fibrillation
Atrial Fibrillation - epidemiology
Cardiac arrhythmia
Epidemiology
Health aspects
Humans
Obesity
Obesity - epidemiology
Risk factors
Strategic planning (Business)
Weight control
Weight loss
Title Obesity and atrial fibrillation: making inroads through fat
URI https://www.ncbi.nlm.nih.gov/pubmed/32096865
https://www.proquest.com/docview/2513197733
https://www.proquest.com/docview/2364034872
Volume 7
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhR1daxNBcND2xRfR-hWNZRWpL11y3bndu9MHaUtLEaxBUsjbsdkPVOolNmmh_96Zu01CKOrjscPuMR87HzsfAO-sKULlUMmovJd5tFGWAb0solOGXAyMyMXJX87N2UX-eazHKeA2T2mVyzuxvaj91HGMfEB6mLilKBA_zX5LnhrFr6tphMZ92ObWZczVxbhYx1i4_KHtxKkyraUhZ2zVtxEH4ftPdzMbzG6szQ5wQy-l23mj5O2O5dlqoNNH8DCZjuKwo_VjuBeaHdgbdr2nb_fFaF1KNd8Xe2K47kp9-wQ-phEAwjZe2HZYh4ic73_ZZcN9EL_awVTiR3M1tX4u0gQfEe3iKVycnoyOz2SanCCdxmwhDYlVYa1TKgZl0GCMnmjiSWJDWdmD0pcYK60nHh2ZXBaz0ofcGFexwxg1PoOtZtqEFyCs5YrCfBLzKubofRXjJOSeNJ7VRGjVA7nEW-1SW3GebnFZd8_bWHd4rhOee_B-BT_rGmr8HZLJULOk0Y7OpoIB-i_uWVUfkmOfVfQjugf9DUiSELex_JYI-d_T-ks610mM5_Wa6XrwZrXM23NqWhOm1wSDJs-Q_D5CxfOOP1ZHoSIPsTT65b83fwUPFKfKtJGdPmwtrq7Da7J1FpPdlqF3Yfvo5Hz4jb5GX8d_ADYiANM
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1LbxMxELaqcoAL4k0ggEFQLrWy9ex6d0EIVUCV0od6SKXcXMcPQdVuQpMW5U_xG5nZ9SaKEHDq2ZZtjT97ZuyZ-Rh7bVTuSwtSBOmcSIMJovDgRB6sVOhiQABKTj44VP3j9OswG66xX20uDIVVtndifVG7saU38h7qYURLngN8nPwQxBpFv6sthUYDiz0__4ku2_TD7mfc3zdS7nwZfOqLyCogbAbJTCiEXG6MlTJ4qUBBCA7X6xDNvijNVuEKCGWWjRxYNEcMJIXzqVK2JGcqEEsEXvk3UPEm5Ozlw3z5pkPpFnXlT5lkmVDo_C3qRELPfzu1V5Pe5MqYZAtW9GDUBispdn9YurXG27nDbkdTlW832LrL1nx1j20cNbWu55t8sEzdmm7yDX60rII9v8_eR8oBbirHTU0OwgPlF5w10Xfv-HlNhMW_Vxdj46Y8MgbxYGYP2PG1yPQhW6_GlX_MuDGUwZiOQlqGFJwrQxj51KGGNRkCS3aYaOWmbSxjTmwaZ7r5TgfdyFlHOXfY20X_SVPA4-89aRs0nWwc0ZqYoIDrohpZeluVVKEKLcIO6670xBNpV5pf4Ub-d7Zuu886XhtTvQR5h71cNNPwFApX-fEl9gGVJoB-JoriUYOPxVQg0SMtVPbk34O_YDf7g4N9vb97uPeU3ZIUplO_KnXZ-uzi0j9DO2s2el6Dm7OT6z5NvwFLyDo0
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Obesity+and+atrial+fibrillation%3A+making+inroads+through+fat&rft.jtitle=European+heart+journal.+Cardiovascular+pharmacotherapy&rft.au=Javed%2C+Saad&rft.au=Gupta%2C+Dhiraj&rft.au=Lip%2C+Gregory+Y.H&rft.date=2021-01-01&rft.pub=Oxford+University+Press&rft.issn=2055-6837&rft.volume=7&rft.issue=1&rft.spage=59&rft_id=info:doi/10.1093%2Fehjcvp%2Fpvaa013&rft.externalDocID=A690092125
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2055-6837&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2055-6837&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2055-6837&client=summon